Over Merck Objections, N.J. Judge Combines Vioxx Cases for Trials

The judge presiding over 3,500 Vioxx cases in New Jersey has set Feb. 27 as the next trial date, this time for a consolidated trial of two plaintiffs' claims, despite drug maker Merck & Co.'s urging that each case be decided on its own facts. Judge Carol Higbee grouped the cases based on the alleged damage as well as the length of time the plaintiffs took the prescription painkiller. Plaintiffs lawyers, who favor consolidation, say the groupings could avoid duplication of evidence.

This article requires premium access

This article requires premium access to Law.com. Please sign in or subscribe to read the full text.